ASM Initiatives for COVID-19
- May 20: ASM Hosts COVID-19 Webinar with CDC
- May 12: ASM Statement in Response to Senate HELP Committee Hearing on COVID-19
- May 4: ASM President Robin Patel addressed stakeholders on the weekly Centers for Disease Control and Prevention (CDC) Clinical Laboratory COVID-19 Response conference call. Her presentation discussed ASM's response to date to the pandemic, including support for research, support for clinical microbiologists, and communication with policymakers, stakeholders and the public. Access the recording, slides and call transcript.
- May 4: Two Drugs Show Promise Against COVID-19
- May 4: ASM Thanks FDA for Clarifying SARS-CoV-2 Serology Test Guidance
- April 27: White House Coronavirus Task Force Continues to Work with ASM to Ensure Their Testing Plans are Effective and Efficient
- April 24: ASM Statement on the Paycheck Protection Program and Health Care Enhancement Act
- April 21: ASM Urges FDA to Affirm Role of Clinical Labs for COVID-19 Serology Testing
- April 21: ASM Endorses Bipartisan Letter in Support of Emergency Funding for Research Labs in Next COVID-19 Package
- April 20: White House Coronavirus Task Force Looks to ASM for Assistance Mapping Testing Capacity and Equipment in Each State
- April 17: White House Coronavirus Task Force Calls on ASM to Help Coordinate Testing Ramp Up
- April 15: ASM Launches a COVID-19 Research Registry
- April 14: ASM Submits Letter to FDA Calling for Stronger Oversight of COVID-19 Serology Tests
- April 3: Protocol to Verify Emergency Use Authorization (EUA) COVID-19 Diagnostic Tests
- March 30: ASM Leads Stakeholder Letter Urging a Review of COVID-19 Response to Prepare for Future Pandemics
- March 27: The Value of Diagnostic Testing for SARS-CoV-2: When, Whom, What and How Often To Test?
- March 27: ASM COVID-19 International Summit Sets Research Priorities
- March 26: Breakdown of the Coronavirus Aid, Relief, and Economic Security (CARES) Act
- March 23: Antimicrobials and COVID-19: Strategies for Treating a Pandemic
- March 23: Researchers Investigate Potential Treatments for COVID-19
- March 20: Top COVID-19 Questions, Answered: An Interview with ASM President Robin Patel
- March: 17 ASM Asks Congress for a High-Level, Comprehensive Review of the SARS-CoV-2 Response
- March 17: ASM Commends New Guidance to Increase COVID-19 Testing Capacity
- March 11: A Possible Treatment for COVID-19 and an Approach for Developing Others
- March 10: ASM Expresses Concern About Test Reagent Shortages
- March 9: Expediting COVID-19 Testing and Expanding Access to Clinical Labs
- March 4: ASM Applauds Action on Coronavirus Emergency Supplemental Appropriation
- March 3: ASM Urges Senate Support for Coordinated Efforts to Combat COVID-19
- Feb. 28: Amid COVID-19, ASM Voices Concerns about Clinical Access to Tests
- Feb. 28: What to Know About the New Coronavirus: An Interview with Dr. Stanley Perlman
- Feb. 26: ASM Issues Response to House Hearing on FY2021 HHS Budget and Coronavirus
- Feb. 5: ASM Responds to House Hearing on Wuhan Coronavirus
- Feb. 3: Novel Coronavirus Lab Protocols and Responses: Next Steps
- Jan. 31: 2019 Novel Coronavirus (2019-nCoV) Update: Uncoating the Virus
- Jan. 31: Sharing Research Data and Findings Relevant to the Novel Coronavirus (COVID-19) Outbreak
- Jan. 30: Anthony Fauci Addresses Coronavirus at ASM Biothreats Conference
- Jan. 30: Novel Coronavirus (COVID-19) Receptors Show Similarities to SARS-CoV, According to New Analysis
- Jan. 30: ASM Provides Free Access to Coronavirus Research Articles